Trial Profile
Pramlintide Combined With Model Predictive Control Algorithm
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Pramlintide (Primary) ; Insulin
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ALM002
- 19 Sep 2011 New trial record